Simon Barry J.
- SEC CIK
- 0001647994
In the past year, 5 open-market sale filings worth $4.14M and no purchases.
Current role at each company
- IBRX ImmunityBio, Inc.Directoras of Jun 26, 2026
- VIRX Viracta Therapeutics, Inc.Directoras of Jun 24, 2024
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $4.14M
- 5 filings
- Net
- −$4.14M
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Simon Barry J. as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
IBRX ImmunityBio, Inc.
Director5 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 26, 2026 (view filing) | Jun 24 | 2 days | Simon Barry J.Director | SSale | −25.0K | $7.88 | −$197.0K | −0.9%2.80M after | 10b5-1 |
| Jun 5, 2026 (view filing) | Jun 4 | 1 day | Simon Barry J.Director | SSale | −23.0K | $7.18 | −$165.4K | −0.8%2.83M after | 10b5-1 |
| Feb 26, 2026 (view filing) | Feb 24 | 2 days | Simon Barry J.Director | SSale | −75.0K | $12.01 | −$900.8K | −2.6%2.85M after | 10b5-1 |
| Feb 24, 2026 (view filing) | Feb 20-23 | 4 days | Simon Barry J.Director | SSale | −175.0K | $10.19 | −$1.78M | −5.6%2.93M after | 2 lots10b5-1 |
| Jan 21, 2026 (view filing) | Jan 20 | 1 day | Simon Barry J.Director | SSale | −152.0K | $7.20 | −$1.09M | −4.7%3.09M after | 2 lots10b5-1 |